Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS

Integrated Diagnostics for Prostate Cancer

Project description

Artificial intelligence to support early prostate cancer diagnostics

Prostate cancer is the most common type of cancer in men and their second leading cause of death; however, it is highly treatable in the early stages. Recent studies and clinical trials have demonstrated the efficiency of prostate MRI in early diagnosis, with 5 times less missed cancer cases and 25 % fewer biopsies. Care standards now recommend MRI prior to every biopsy, leading to an increased demand for prostate MRI scans. Conventional radiology reading capacity cannot keep pace with the demand. Quantib BV (Netherlands) developed an AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists. The current EU-funded ID-PROSTATE project allows further improvement and acceleration focusing on product commercialization.

Objective

Quantib Prostate is an AI-enhanced solution to enable an integrated diagnostic care pathway for prostate cancer between urologist, radiologist and pathologist. Prostate cancer is the most prevalent form of cancer in men and their second leading cause of death. Recent high-impact clinical trials have demonstrated the utility of prostate MRI in the care-pathway: 5x fewer missed cancers, 25% fewer biopsies. These trials resulted in changes in care standards per 2019, now recommending MRI prior to every biopsy, resulting in a strong demand increase for prostate MRI scans.

Conventional radiology reading capacity cannot keep pace with that demand due to long staff training times. Quantib Prostate addresses this issue with AI-algorithms that detect potential tumors and workflow enhancements that reduce reporting time.

This project allows Quantib to accelerate and further improve Quantib Prostate.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Coordinator

QUANTIB BV
Net EU contribution
€ 2 100 371,88
Address
WESTBLAAK 130
3012 KM Rotterdam
Netherlands

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
West-Nederland Zuid-Holland Groot-Rijnmond
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 000 531,25